Equities

Vsee Health Inc

VSEE:NAQ

Vsee Health Inc

Actions
FinancialsOpen End and Miscellaneous Investment Vehicles
  • Price (USD)1.29
  • Today's Change-0.06 / -4.44%
  • Shares traded71.93k
  • 1 Year change-89.81%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments0.000.110.76
Total Receivables, Net------
Total Inventory------
Prepaid expenses--00.46
Other current assets, total------
Total current assets0.000.111.22
Property, plant & equipment, net------
Goodwill, net------
Intangibles, net------
Long term investments1.377.53117
Note receivable - long term------
Other long term assets------
Total assets1.377.63118
LIABILITIES
Accounts payable------
Accrued expenses0.10----
Notes payable/short-term debt1.550.690.04
Current portion long-term debt/capital leases------
Other current liabilities, total3.040.72--
Total current liabilities7.983.300.18
Total long term debt000
Total debt1.550.690.04
Deferred income tax------
Minority interest------
Other liabilities, total4.374.374.37
Total liabilities127.674.55
SHAREHOLDERS EQUITY
Common stock1.287.40117
Additional paid-in capital0.550.290
Retained earnings (accumulated deficit)(13)(7.72)(3.33)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity(11)(0.03)113
Total liabilities & shareholders' equity1.377.63118
Total common shares outstanding3.601515
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.